miRNA-23a has effects to improve lung injury induced by sepsis in vitro and vivo study
Abstract
Aim The aim of this study is to explain the effects and mechanism of miRNA-23a in lung injury which were induced by sepsis in vitro and vivo. Methods In the vitro study, The BEAS-2B cells were divided into 4 groups: NC, MC, miRNA and miRNA + PTEN agonist groups. The cell proliferation and apoptosis of difference groups were measured by MTT and flow cytometry, the relative proteins expression of difference groups were measured by WB assay. In the vivo study, the rats were also divided into 4 groups: NC, MC, miRNA and miRNA + PTEN agonist groups. The miRNA-23a expression of difference groups were evaluated by ISH in lung tissues of rats. The cell apoptosis of difference groups were evaluated by TUNEL assay in lung tissues; the relative proteins expression of difference groups were evaluated by IHC assay. Results Compared with NC group, the cell apoptosis rate of MC groups were significantly increased in vitro and vivo studies (P < 0.05, respectively). The relative proteins (PTEN, PI3K, AKT and P53) expressions of MC group were significantly differences (P < 0.05, respectively) compared with those of NC groups in vitro and vivo studies. However, with miRNA-23a infection, the cell apoptosis of miRNA group were significantly suppressed compared with MC groups, and the relative proteins (PTEN, PI3K, AKT and P53) of miRNA group were also significantly differences compared with MC groups in vitro and vivo studies (P < 0.05, respectively). Conclusion The miRNA-23a has improved lung in…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
miR-23a can improve sepsis-induced lung injury through the PTEN/PI3K/AKT/P53 pathway.
“Functional studies both in vivo and in vitro have implied that miR-23a can also improve sepsis-induced lung injury through the PTEN/PI3K/AKT/P53 pathway [36].”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [36]
The citation lists haven’t been fetched yet
References 27 · Cited by 24
- Authors
- Yang, J., Mao, M., & Zhen, Y.-Y.
- Affiliations
- Qilu Hospital of Shandong University (CN)
- Corresponding author
- Yang, Jing
- ORCID
- Yang, Jing
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 107
- Pages
- 81-89
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W2887589341
- Cited by
- 24
- References
- 27
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 8 · 2020: 2 · 2019: 3
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Biomedicine & Pharmacotherapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Keywords
- sepsis-induced lung injury, PTEN, PI3K/Akt signaling, p53, apoptosis, BEAS-2B cells, miRNA-based therapy
- MeSH terms
- Animals, Cell Cycle, Cell Line, Humans, Male, Tumor Suppressor Protein p53, Rats, Wistar, Apoptosis, Sepsis, Phosphatidylinositol 3-Kinases, MicroRNAs, Cell Proliferation, Proto-Oncogene Proteins c-akt, Lung Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review